1. Home
  2. TRIP vs AMPH Comparison

TRIP vs AMPH Comparison

Compare TRIP & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TripAdvisor Inc.

TRIP

TripAdvisor Inc.

N/A

Current Price

$9.77

Market Cap

1.1B

Sector

Technology

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$18.77

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRIP
AMPH
Founded
2000
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2011
2005

Fundamental Metrics

Financial Performance
Metric
TRIP
AMPH
Price
$9.77
$18.77
Analyst Decision
Hold
Buy
Analyst Count
13
7
Target Price
$14.88
$30.29
AVG Volume (30 Days)
4.1M
525.8K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
675.00
N/A
EPS
0.31
2.03
Revenue
$1,556,000,000.00
$719,887,000.00
Revenue This Year
$3.33
$7.34
Revenue Next Year
$5.12
$4.81
P/E Ratio
$31.71
$9.25
Revenue Growth
N/A
N/A
52 Week Low
$9.46
$18.52
52 Week High
$20.16
$31.26

Technical Indicators

Market Signals
Indicator
TRIP
AMPH
Relative Strength Index (RSI) 32.69 23.66
Support Level $9.54 N/A
Resistance Level $15.37 $28.56
Average True Range (ATR) 0.47 1.22
MACD 0.10 -0.69
Stochastic Oscillator 8.16 2.18

Price Performance

Historical Comparison
TRIP
AMPH

About TRIP TripAdvisor Inc.

Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2024, 52% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform (33% of 2024 sales). Viator, its experiences brand, was 46% of revenue in 2024, and TheFork, its dining brand, represented 10% of sales (about 8% of revenue were intersegment, which are eliminated from consolidated revenue).

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: